baber/WOPTO huggingface dataset:
Patent IL-102752-A0 (IL)
Title: Composition containing a thiazol-urea derivative for controlling vegetation
IPC: A01N43/832
Filed: 1992-08-06
Abstract: Compositions and methods for vegetation control comprise synergistic combinations of a thiazol-urea abscission agent and an adduct formed by the reaction of sulfuric acid with an amide. The synergistic combinations are particularly useful for the defoliation of cotton.
Patent IL-106450-A0 (IL)
Title: Improvements in or relating to benzothiophenes
IPC: A61K31/38
Filed: 1993-07-22
Abstract: The use of raloxifene, or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for preventing or treating osteoporosis in a postmenopausal woman.
Patent IL-109496-A0 (IL)
Title: Substituted pyrrolidin-3-yl-alkyl-piperidines and pharmaceutical compositions containing them
IPC: A61K31/535
Filed: 1994-05-02
Abstract: The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.
Patent IL-114220-A0 (IL)
Title: Procatalyst for ethylene polymer production method for its preparation and use
IPC: C08F4/646
Filed: 1995-06-20
Abstract: The invention relates to a high activity procatalyst for the production of ethylene polymers, which procatalyst comprises a particulate inorganic support, a chlorine compound carried on said support, a magnesium compound carried on said support, and a titanium compound carried on said support, wherein the chlorine compound is the same as or different from the magnesium compound and/or the titanium compound. Said procatalyst has an activity balance AB in specified polymerization conditions, which is greater than 3.2, wherein AB = Ä(A + A'):2 . log (MFR2' : MFR2) : (A - A')Ü, A presents the polymerization activity of said procatalyst expressed as kg PE / g cat . h, MFR2 means the melt flow rate of polyethylene produced by said procatalyst expressed in g/min units at a load of 2.16 kg, according to the standard ISO 1133, the absence of the upper index ' means low melt flow rate polymerization and the presence of the upper index ' means high melt flow polymerization.
Patent IL-114719-A0 (IL)
Title: N-substituted azabicycloheptane derivatives their preparation and use thereof
IPC: A61P43/00
Filed: 1995-07-25
Abstract: PCT No. PCT/EP95/02912 Sec. 371 Date Feb. 3, 1997 Sec. 102(e) Date Feb. 3, 1997 PCT Filed Jul. 22, 1995 PCT Pub. No. WO96/04245 PCT Pub. Date Feb. 15, 1996A compound of the formula   <IMAGE>   in which A, R1 and n have the meanings stated in the description are described. The novel compounds are suitable for controlling diseases.
Patent IL-124574-A0 (IL)
Title: Door security arrangement
IPC: E05B53/00
Filed: 1996-11-22
Abstract: PCT No. PCT/GB96/02887 Sec. 371 Date May 20, 1998 Sec. 102(e) Date May 20, 1998 PCT Filed Nov. 22, 1996 PCT Pub. No. WO97/20124 PCT Pub. Date Jun. 5, 1997A door security arrangement with the frame member which is mountable in a wall alongside the opening edge of a door and has an elongate member slideably mounted therein, the member being substantially the same length of the door edge and being movable from a retracted position in which it lies within the frame member and permits the door to swing past it to an extended position in which it lies alongside and substantially against the inner face of the door and the arrangement including releasable means, located within the frame member which hold the elongate member in its retracted and extended positions and are operable by the normal door locking mechanism.
Patent IL-130908-A0 (IL)
Title: Tissue-factor (tf) compositions for coagulation and tumor treatment
IPC: A61K47/48
Filed: 1998-01-20
Abstract: The invention embodies the surprising discovery that Tissue Factor (TF) compositions and variants thereof specifically localize to the blood vessels within a vascularized tumor following systemic administration. The invention therefore provides methods and compositions comprising coagulant-deficient Tissue Factor for use in effecting specific coagulation and for use in tumor treatment. The TF compositions and methods of present invention may be used alone, as TF conjugates with improved half-life, or in combination with other agents, such as conventional chemotherapeutic drugs, targeted immunotoxins, targeted coaguligands, and/or in combination with Factor VIIa (FVIIa) or FVIIa activators.
Patent IL-135912-A0 (IL)
Title: Process to produce oxazolidinones
IPC: C07C251/24
Filed: 1998-10-13
Abstract: The present invention includes a number of novel intermediates such as the (S)-secondary alcohol of formula (VIIIA) X 2 -CH 2 -C*H(OH)-CH 2 -NH-CO-R N  and processes for production of pharmacologically useful oxazolidinones.
Patent IL-142851-A0 (IL)
Title: Method and apparatus for new device driver installation by an operating system
IPC: G06F9/445
Filed: 1999-10-28
Abstract: A method and apparatus are disclosed for inputting new device driver information into a Personal Computer (PC) in an existing computer network so as to enable the Operating System (OS) to recognize the new hardware device during installation of the OS and to permit the OS to automatically install the associated device driver.
Patent IL-153076-A0 (IL)
Title: Apparatus for automated ophthalmic lens fabrication
IPC: B29L11/00
Filed: 2000-12-15
Abstract: An apparatus for the automated production of ophthalmic lenses, particularly compound lenses having a plastic coating on a plastic lens is described. A mold, after rotational orientation, is placed in a gimbal assembly to provide for the proper tilt. This gimbal assembly forms part of a fixture attached to an indexing means which moves for complete assembly of a molding fixture and then moves the molding fixture through a chamber to cure the resin. A preform, after rotational orientation, is held, by a preform gripper placed above the mold, and with sufficient clearance between the mold and the preform to allow the correct resin thickness during the curing portion of the process. The fixture is also provided with members to firmly grip the preform gripper so as to maintain its orientation throughout the curing process.
Patent IL-156335-A0 (IL)
Title: System and method for inband signaling for sector synchronization in a wireless communication system
IPC: H04B7/26
Filed: 2001-12-10
Abstract: The present invention relates to a system and method for frequency re-use in a wireless communication system. More particularly, the inventive system and method provides for maximum coverage of a service area with a pattern of cells (101, 102, 103 and 104) each having a sectorized (101A-101D) hub (105) antenna pattern (202A-202D) where only a limited number of communication channels are available.
Patent IL-163998-A0 (IL)
Title: Method and apparatus for energy and data retentionin a guided projectile
IPC: F42C15/40
Filed: 2003-05-30
Abstract: Energy (110) and mission data (108) for a guided projectile are transferred from a projectile setter (102) over an inductive interface (118). The projectile may include energy storage element (114) to store the energy and a data storage element (112) to store the mission data. Precision GPS clock circuitry (316) of the projectile may receive power from a capacitive energy storage (304) element during projectile loading until a flight battery (320) is activated. In one embodiment, the capacitive energy storage element (304) includes at least one super capacitor (322) and a gun-hardened capacitor (324). The clock circuitry (316) may receive power from the gun-hardened capacitor (324) if the super capacitor (322) fails during the launching operation. The capacitive energy storage element (304) may include one-way energy transfer elements (326) coupled between the super capacitor (322) and the gun-hardened capacitor (324). A regulator (312) may be coupled to an output of the capacitive storage element (304) to regulate an input voltage to the clock circuitry (316).
Patent IL-164997-A0 (IL)
Title: Spiral wound element with improved feed spacer
IPC: B01D63/10
Filed: 2004-11-02
Abstract: The present invention is an improved feed spacer, spiral wound element incorporating said feed spacer, filtration system and a method for making and using the same. In one embodiment the present invention includes an improved spiral wound element having: a central collection tube with a plurality of openings along its length to receive permeate; at least one filtration envelope extending outwardly from and wound about the tube and at least one feed spacer sheet wound about the collection tube wherein the feed spacer sheet being in planar contact with the outer surface of at least one filtration envelope. The feed spacer sheet is a net comprising a first set of substantially parallel filaments crossed with a second set substantially parallel filaments to form a plurality of parallelograms having an acute angle less than 70°, the net oriented such that a line bisecting said acute angle is approximately parallel to the axis of the central collection tube and wherein the net has a strand thinning parameter greater than 1.3.
Patent IL-175754-A0 (IL)
Title: 3-aminopyrrolidone derivatives
IPC: A61K31/4412
Filed: 2006-05-18
Abstract: This invention is related to compounds and use of 3-aminopyrrolidone derivatives and analogues of the following general formula (I) <CHEM> wherein  m is an integer from 1 to 3 X is methylene, oxygen, sulphur or a NR<6> group; R<1>   is a straight or branched C1-C8 alkyl or C3-C8 alkenylene or C3-C8 alkynylene chain, optionally substituted with CF3, phenyl, phenoxy or naphthyl, the aromatic rings optionally substituted by one or more C1-C4 alkyl, halogens, trifluoromethyl, hydroxy or C1-C4 alkoxy groups; R<2>, R<3>   are independently hydrogen, a C1-C3 alkyl chain, halogen, trifluoromethyl, hydroxy or C1-C4 alkoxy groups; R<4>, R<5>, R<6>   are independently hydrogen or C1-C6 alkyl;  and the pharmaceutically acceptable salts thereof that are active as sodium and/or calcium channel modulators and therefore useful in preventing, alleviating and curing a wide range of pathologies, including, but not limited to, neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urologic, metabolic and gastrointestinal diseases, where the above mechanisms have been described as playing a pathological role.
Patent RO-128633-A0 (RO)
Title: Plant for burning coal dust in admixture with hydrogen-enriched gas () for reducing sulphur dioxide emissions and corrosive depositions
Inventor: PRISECARU TUDOR
IPC: C10L10/00
Filed: 2012-03-07
Abstract: The invention relates to an plant for burning coal dust in admixture with a hydrogen-enriched gas, for reducing sulphur dioxide emissions and the corrosive depositions. According to the invention, the plant consists of a chamber (1) for mixing the gas with the coal dust, a pipe (2) for blasting the hydrogen-enriched gas, a section (3) for distributing the mixture, through some intake slots (5) of various lengths, into a burning furnace (4).
Patent RO-137239-A0 (RO)
Title: Process for preparing a hydrogel from cardiac tissue functionalized with an anti-inflammatory agent
Inventor: CECOLTAN SERGIU
IPC: C07K14/78
Filed: 2022-08-25
Abstract: The invention refers to a process for preparing a functionalized hydrogel to be used in the regenerative medicine of the myocardium damaged after myocardial infarction (MI). According to the invention, the process consists of the following steps: decellularization of murine or porcine myocardium by hypotonic shock, protein extraction with detergent, nuclease digestion with specific enzymes, freezing and lyophilization of the acellular matrix for 72 h at -48°C and 0.045 mBar, addition of an acid solution of 10 mM HCl and porcine pepsin at the final concentration of 160 U/mg of matrix, neutralization of the acidic pH with 1M NaOH solution, followed by incubation for 90 min in the incubator, resulting in a hydrogel containing glycosaminoglycans and proteins of extracellular matrix collagen I and IV, elastin, fibronectin and laminin, being functionalized with an anti-inflammatory compound of the S100A9 alarmin inhibitor type for intervention in the inflammatory phase of post MI pathological evolution.
Patent AP-2004003021-A0 (AP)
Title: Vectors, constructs and transgenic plants for HPV-11 and HPV-16 L1 capsid protein.
Inventor: VARSANI ARVIND DEVSHI
IPC: C07K14/025
Filed: 2002-08-30
Abstract: Vectors and/or constructs of human papillomavirus genes are used in transforming host cells, such as bacteria, yeast cells, fungal cells, insect cells, mammalian cells and plant cells. The host cells are cultivated under conditions which permit spotaeousamly of at least one protein fragment of a protein encoded by the vector and/or gene construct into an immunogenic-response elicitig virus-like particle directed against human papillomavirus.
Patent ZW-3092-A1 (ZW)
Title: Fluoroalkenyl compounds and their use as pest repellents
Inventor: PETER GERRARD RUMINSKI
IPC: A01N37/26
Filed: 1992-02-28
Abstract: Trifluorobutenoic acid, its methyl ester and a process of preparation thereof.
Patent ZW-7882-A1 (ZW)
Title: Pharmaceutical compositions
Inventor: BRITTAIN DAVID ROBERT
IPC: C07D487/10
Filed: 1982-04-21
Abstract: The invention provides a pharmaceutical composition comprising an aldose reductase inhibitory 1'-substituted-spiro[pyrrolidine-3,3'-indoline]-2,2', 5-trione of the formula:wherein Ra is (2-7 C) alkyl or (3-7 C) alkenyl, naphthylmethyl or cinnamyl optionally bearing one or two halogeno nuclear substituents, or Ra is benzyl optionally bearing one or two sub- stltuents and benzene ring A optionally bears one or two substituents, trifluoromethyl and nitro; or a salt thereof with a base affording a pharmaceutically acceptable cation; or a non-toxic, biodegradable precursor thereof; together with a pharmaceutically a-ceptable diluent or carrier. The invention also provides novel compounds of formula I and processes for their manufacture.The compositions are of application in the treatment or prophylaxis of the side effects of diabetes or galactosemia.
Patent MA-20532-A1 (MA)
IPC: A01N43/16
Filed: 1985-09-24
Abstract: The invention provides a process for preparing a 4-hydroxycoumarin derivative having anti-coagulant properties, useful as a rodenticide, of formula <CHEM> wherein R<1> and R<2> are independently selected from the group consisting of hydrogen, halogen, alkyl of up to 6 carbon atoms and alkoxy of up to 6 carbon atoms, and R<3> represents a group selected from <CHEM> where X represents a halogen atom or a group C1 12 alkyl, C1 12 alkoxy, C3-8 cycloalkyl, CN, SO2R<5>, CF3, OCF3, COOR<5> or COR<5>, where R<5> is C1 6 alkyl, n min  is 0, 1 or 2 and Y is a fluorine or chlorine atom; <CHEM> where n min  and Y are as defined above, X is as defined above or is hydrogen, n sec  is 0 or 1 and D is an oxygen atom or a group -O-(CH2)m-, -(CH2)m-O-, -O-(CH2)m -O-(CH2)p-, -(CH2)-m, or -CH=CH-, or a sulphur ana logue thereof, wherein m is in the range 1 to 6 and p is in the range 1 to 6; <CHEM>  where X, n min  and Y are as defined in (a) above.  (d) a group selected from <CHEM>  and <CHEM>  and  (e) a group selected from <CHEM> where X and n sec  are defined as in (b) above, A is an oxygen or sulphur atom and D min  is an oxygen atom or a -CH2- group, which process comprises condensing 4-hydroxycoumarin with a compound of formula <CHEM> or the corresponding 1,2-dihydronaphthalene, wherein R<1>, R<2> and R<3> are as defined above, and L is a hydroxy group or a halogen aotm, in the presence of an organic solvent and a catalyst characterised in that the solvent is selected from formic acid, a mixture of formic acid and at least one C2-6 aliphatic acid having a boiling temperature at atmospheric pressure in the range 60 DEG C to 105 DEG C and a liquid halogenated hydrocarbon having a boiling temperature of at least 60 DEG C, and reaction is effected at a temperature in the range 60 DEG C to the reflux temperature of the reaction mixture.
Patent MA-21826-A1 (MA)
Inventor: JACQUES PERSELLO
IPC: A61Q11/00
Filed: 1990-05-02
Abstract: Silica capable of being employed in particular in dentifrice compositions and compatible especially with organic amino compounds. The silica of the invention is characterised in that it results in an aqueous suspension whose pH varies according to defined equations, depending on its concentration and its electrical conductivity.
Patent MA-22591-A1 (MA)
Inventor: SK HEDGER
IPC: C11D17/00
Filed: 1992-07-13
Abstract: The invention provides a personal cleansing freezer bar comprising a skeleton structure having a relatively rigid, interlocking, semi-continuous, open, three-dimensional, crystalline mesh of neutralized carboxylic acid soap selected from the group consisting of sodium soap; wherein said bar is made by the following steps: (1) mixing a molten mixture comprising by weight of said bar: from about 15% to about 85% of said soap and from about 15% to about 40% water; (2) cooling said mixture to a semi-solid in a scraped wall heat exchanger freezer; (3) extruding said semi-solid as a soft plug; and (4) further cooling said soft plug to provide said personal cleansing bar.
Patent MA-25526-A1 (MA)
Inventor: GIMET RENE
IPC: A61K9/00
Filed: 2001-10-23
Abstract: Dispersible tablets containing 20 - 60 % by weight of a macrolid (I) and 1 - 25 % of a disintegration agent (II) together with a sweetening agent. (I) is present as the base and is one or more of the following: pristinamycin, azithromycin, roxithromycin, clarithromycin, and spiramycin. The disintegrating agent (II) is preferably 1 - 16 % polyvinyl pyrrolidone, 1 - 15 % sodium croscarmellose or a 1:1 - 4:1 mixture of these two. The sweetening agent is preferably aspartame, sodium saccharin, potassium acesulfame, ammonium glycerinate, or their mixtures. The tablets may further contain an active nitro-imidazole, especially metronidazole, tinidazole or ornidazole, as well as conventional diluents, surfactants, lubricants, flow agents and flavors. ACTIVITY : Antibiotic. MECHANISM OF ACTION : None given.
Patent MA-39226-A1 (MA)
Title: Nouveau procédé multi-chemin de sécurité dans les réseaux manet
Inventor: HABBANI AHMED
IPC: H04W40/00
Filed: 2016-07-26
Abstract: Notre invention apporte une solution face aux limites de sécurité qui menace la confidentialité, l'intégrité et la disponibilité. Cette invention propose une nouvelle méthode pour trouver un nombre n variable des chemins multiples, avec un seuil égale à k, en évaluant le réseau et les points d'intersection entre les chemins. Elle permet au noeud de prendre la décision sur le nombre des chemins selon la situation, en fiabilisant les routes pour les prochaines communications.
Patent UY-24986-A1 (UY)
Title: Compuestos
Inventor: LESLIE BRANCH CLIVE
IPC: A61P25/18
Filed: 1998-04-30
Abstract: Nuevos derivados de tetrahidroisoquinoleina, procedimientos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia, como moduladores de los receptores d3 de la dopamina, en particular como agentes antippsicóticos
Patent UY-25280-A1 (UY)
Title: Derivados de ácido hidroxámico como inhibidores de metaloproteasas de matriz (mmp)
Inventor: WHITLOCK GAVIN ALISTAIR
IPC: A61P35/04
Filed: 1998-12-03
Abstract: La presente invención se refiere a derivados de ácido hidroxámico de fórmula (I), en la que la línea a trazos representa un enlace opcional; A es C o CH; B es CH2, O o está ausente; cada uno de R1 y R2 se selecciona, independientemente, entre H, alquilo, alquenilo, o junto con el átomo de carbono al que están unidos, forman un grupo cicloalquilo; R3 es H, halo, R7 u OR7; R4 es H, alquilo, alcoxi, trifluorometilo o halo; R7 es un sistema de anillo monocíclico o bicíclico, seleccionado entre fenilo, tienilo, furilo, piridinilo, pirimidinilo, naftilo, indanilo, benzotienilo, benzofuranilo, indolilo, quinolinilo, benzoimidazolilo, benzotiazolilo y benzodioxanilo; m es 1 ó 2; n es 0, 1 ó 2; y a sales farmacéutica o veterinariamente aceptables de los mismos. Estos compuestos son inhibidores de ciertos miembros de la familia de metaloproteasas de matriz (MMP), y como tales, son útiles en tratamientos de enfermedades cardiovasculares, angiogénesis tumoral, enfermedad fibrótica, artritis reumatoide, osteoartritis. Ej. no limitante: N-hidroxi-2-[4-[4-(3-etoxifenil)-3-metilfenil]-1,2,3,6-tetrahidropiridin-1-ilsulfonil]acetamida
Patent UY-26428-A1 (UY)
Title: Composición cosmética adelgazante que contiene una substancia inductora de la producción de il-6
Inventor: PIERRE CASELLAS
IPC: A61Q19/00
Filed: 2000-11-03
Abstract: La invención se refiere a composiciones cosméticas que contiene substancias activas adelgazantes que se eligen entre un antagonista de receptores del neuropéptido y en adelante denominado NPY, un antagonista de los receptores alfa2 y un inductor de la producción de interleuquina-6 en adelante denominado IL-6. El NPY antagonista, el alfa 2 antagonista o el inductor de la producción de IL-6 puede ser un compuesto no peptídico, un péptido, un extracto de células o de tejido de origen animal o vegetal o un producto obtenido por fermentación de un microorganismo, por ejemplo de una bacteria o de un hongo.
Patent UY-27149-A1 (UY)
Title: Película laminar multilaminar, estirada biaxialmente y sellable para envasar y envolver carne, carne con hueso y alimentos en estado pastoso, como también su uso.
Inventor: GRUND HARTMUT
Filed: 2002-02-01
Abstract: La presente invención se refiere a una película tubular penta laminar, estirada biaxialmente, encogible y sellable para envasar y envolver carne o carne con hueso, como también su uso. La película tubular inventiva presenta una lámina interior intermedia de poliolefina, como también una lámina exterior de al menos una homo poliamidas, como también dos láminas de material adherente dispuestas entre lámina interior y la lámina intermedia. Tales películas se caracterizan por una mayor resistencia de la costura de soldadura como también resistencia a la penetración.
Patent UY-29984-A1 (UY)
Inventor: BROZE GUY
IPC: C11D17/00
Filed: 2006-11-30
Abstract: Cleaning compositions are described comprising an aqueous component: an organic solvent; an anionic surfactant; an amine co-surfactant containing either (a) an N-oxide group or (b) a zwitterionic group; and a nonionic surfactant; in a form of a microemulsion or microemulsion preconcentrate. Methods of cleaning a hard surface using such compositions are also described.
Patent UY-30992-A1 (UY)
Title: Derivados de arilisoxazolina insecticidas
Inventor: BACH THOMAS DR
IPC: A01N43/40
Filed: 2008-03-31
Abstract: La presente invencion se refiere a nuevos derivados de arilisoxazolina que tienen excelente actividad insecticida como insecticidas y están representados por la formula: y su uso como insecticidas y acaricidas.
Patent UY-31680-A1 (UY)
Title: "agonistas de los receptores muscarínicos, composiciones, métodos de tratamiento en que se emplean y sus procesos de preparación-176"
Inventor: TOMASZEWSKI MIROSLAW JERZY
IPC: C07D235/00
Filed: 2009-02-27
Abstract: Se preparan compuestos de fórmula I, o sus sales farmacéuticamente aceptables: donde X; R1, R2, R3, R4, R5, n, m, y p son como se definen en la especificación así como sus sales y composiciones farmacéuticas que incluyen los compuestos. Son útiles en terapia, en particular en el manejo del dolor.
Patent UY-31769-A1 (UY)
Title: Derivados del indol con actividad modulatoria del receptor nicotínico de acetilcolina
Inventor: MARSHALL HOWARD ROBERT
IPC: A61P25/00
Filed: 2009-04-16
Abstract: Esta invención se refiere a la modulación del receptor nicotínico de acetilcolina (nAChR) a7 por un compuesto de fórmula (I) o una sal del mismo: